HomeACIU • NASDAQ
add
AC Immune SA
Previous close
$3.02
Day range
$2.97 - $3.31
Year range
$1.43 - $4.00
Market cap
313.76M USD
Avg Volume
317.85K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 338.00K | -70.27% |
Operating expense | 60.56M | 1,425.37% |
Net income | -14.37M | 9.01% |
Net profit margin | -4.25K | -206.07% |
Earnings per share | -0.14 | 12.44% |
EBITDA | -14.08M | 22.90% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 91.41M | -44.76% |
Total assets | 154.25M | -33.20% |
Total liabilities | 109.37M | -7.82% |
Total equity | 44.88M | — |
Shares outstanding | 101.74M | — |
Price to book | 6.85 | — |
Return on assets | -22.10% | — |
Return on capital | -61.81% | — |
Cash Flow
Net change in cash
| (CHF) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -14.37M | 9.01% |
Cash from operations | -16.51M | -378.19% |
Cash from investing | 16.00M | 518.27% |
Cash from financing | -261.00K | -32.49% |
Net change in cash | -946.00K | -124.52% |
Free cash flow | -15.41M | -223.64% |
About
Founded
2003
Website
Employees
153
